Growing evidence suggests that hepatic macrophages play an important role in tissue repair after liver injury by coordinating the induction and resolution of inflammation, removing apoptotic cells, and promoting hepatocyte proliferation. Understanding the role of macrophages in the pathogenesis of liver injury will help pave the way to future therapeutics. Here, we investigated whether macrophage p38a plays a regulatory role in the tissue repair following D-galactosamine (GalN)/tumor necrosis factor-a (TNF-a)-induced acute liver injury. We found that macrophage p38a-deficient mice displayed decreased mortality and relieved liver injury as evident from less apoptosis, accelerated regeneration, decreased granulocytes recruitment, monocytes infiltration, and cytokine production after GalN/TNF-a treatment. Mechanistically, we found that p38 signaling was activated by lipopolysaccharide/ interferon-c treatment but not by inteleukin-4 stimulation, while pharmaceutical inhibition of p38a induced a shift in polarization from M1 macrophages to M2 macrophages. Together, our results indicated that macrophage p38a signaling is involved in the pathogenesis of liver injury induced by GalN/TNF-a, and inhibition of p38a signaling in macrophage could ameliorate liver injury and accelerate regeneration, probably by promoting the polarization of macrophages from the M1 phenotype to the M2 phenotype.
Introduction
Drug-induced hepatotoxicity is the leading cause of acute liver failure. D-Galactosamine (GalN) is a hepatotoxin frequently used in the study of liver injury [1] . A high dose of GalN is known to induce apoptosis of hepatocytes in rat and mouse, which is evidenced by histochemical observations, DNA laddering, and caspase 3 activation [2] [3] [4] . The progress of acute GalN toxicity on hepatocytes has been classified into two stages: cell death and regeneration [5] . Liver regeneration is known to be important for survival after GalN Abbreviations ALI, acute liver injury; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMDM, bone marrow-derived macrophage; CCL5, chemokine (C-C motif) ligand 5; CDK, cyclin-dependent kinase; CXCL, C-X-C motif chemokine ligand; ERK, extracellular signal-regulated kinase; GalN, D-galactosamine; H&E, hematoxylin and eosin; IFN-γ, interferon-γ; IL, interleukin; JNK, c-Jun N-terminal kinase; KC, Kupffer cell; KO, knockout; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; MCP-1, monocyte chemoattractant protein-1; MDM, monocyte-derived macrophage; NPC, nonparenchymal cell; PM, peritoneal macrophage; TNF-α, tumor necrosis factor-a; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
overdose, which involves proliferation of both progenitor cells and hepatocytes. Upon GalN injury, progenitor cells proliferate and differentiate into mature hepatocytes [6] , while hepatocytes proliferate to restore the liver mass after GalN treatment [6] [7] [8] . Liver has the largest population (80-90%) of macrophages, which play important roles in the proper regulation of immune responses. It has been widely accepted that, in addition to the direct effects of injurious agents on hepatocytes, cytokines generated by the accompanying innate immune response also contribute to liver injury [9] . Growing evidence suggested that tumor necrosis factor is involved in the pathogenesis of liver injury [10] . Other proinflammatory cytokines may also be cytotoxic to hepatocytes such as interleukin (IL)-1b and interferon-c (IFN-c) [11] [12] [13] [14] .
Macrophages play an important role in innate and adaptive immunity [15] . It has been shown that macrophage cells not only control the inflammatory progresses but also participate actively in the resolution of inflammation and tissue repair by secreting antiinflammatory cytokine [16] . Plasticity and heterogeneity are hallmarks of macrophages [17] , which allow them undergo phenotypic conversion in response to different environmental factors. Classical M1 and alternative M2 activation of macrophages have been investigated extensively [18] . It has been proposed that classical M1-type macrophages suppress the proliferation of surrounding cells and damage contiguous tissue, while alternative M2-type macrophages promote the proliferation of contiguous cells and accelerate tissue repair. Classical M1 macrophages produce and release proinflammatory cytokines, including tumor necrosis factor-a (TNF-a), IL-1 [19] , IL-6, IL-12, IFNc, and C-X-C motif chemokine ligand (CXCL) 1-3 [20] . High levels of nitric oxide (NO) and reactive oxygen intermediates are the typical characteristics of classical M1 macrophages [21] . In contrast, alternative M2 macrophages produce anti-inflammatory cytokines such as IL-10 and a very low level of proinflammatory cytokines such as IL-12 [22] . Other M2 macrophage markers include YM1, arginase 1, and FIZZ1 [23] .
p38 mitogen-activated protein kinase (MAPK) is known to be activated by a variety of environmental stresses and proinflammatory cytokines and mediates intracellular signal transduction [24] [25] [26] . The activation of p38 MAPK requires phosphorylation by MAPK kinases or autophosphorylation triggered by interaction with regulatory proteins. It has been proposed that p38 MAPK regulates transcription through its downstream targets, such as transcriptional regulator ATF2. p38a is highly abundant in most cell types including macrophage cells. Although p38a has been extensively studied in macrophages, its role in macrophages is still controversial [27] . Here, we investigated whether macrophage p38a plays a regulatory role in the tissue repair following a GalN/TNF-a-induced acute liver injury (ALI). We found that macrophage p38a-deficient mice displayed decreased mortality and less liver injury as evident from less apoptosis, accelerated regeneration, decreased granulocytes recruitment, monocytes infiltration, and cytokine production after GalN/TNF-a treatment. Mechanistically, we found that p38 signaling was activated by lipopolysaccharide (LPS)/IFN-c treatment but not by IL-4 stimulation, while pharmaceutical inhibition of p38a induced a shift in polarization from M1 macrophages to M2 macrophages. Together, our results indicated that macrophage p38a signaling is involved in the pathogenesis of liver injury induced by GalN/TNF-a, and inhibition of p38a signaling in macrophages could relieve liver injury and accelerate regeneration, probably by promoting the polarization of macrophages from the M1-like phenotype to the M2-like phenotype.
Results

Loss of macrophage p38a decreased the mortality upon GalN/TNF-a treatment
To determine the role of macrophage p38a in GalN/ TNF-a-induced hepatotoxicity, myeloid cell-specific p38a knockout (KO) (p38a fl/fl LysMCre +/À ) mice (hereafter referred to as Mac-p38a KO mice) were generated. As shown in Fig. 1A , Mac-p38a KO mice had obtained the Cre gene, while control mice had not (Fig. 1A) . The expression of p38a in bone marrowderived macrophages (BMDMs), peritoneal macrophages (PMs), Kupffer cells (KCs), and other tissues were then analyzed. Quantificational real-time polymerase chain reaction (qRT-PCR) analysis of the p38a gene revealed that it was specifically deleted in macrophages from Mac-p38a KO mice (Fig. 1B,C) . Consistent with the qRT-PCR results, western blot analysis also confirmed that the protein expression of p38a was specifically eliminated in macrophages from Mac-p38a KO mice (Fig. 1D,E) . To test whether the loss of p38a in macrophages would have any effect on GalN/TNFa-induced hepatotoxicity, Mac-p38a KO mice were intraperitoneally injected with 100 lgÁkg À1 of TNF-a and 700 mgÁkg À1 of GalN, and the survival rate was examined. Within 10 h after GalN/TNF-a administration, 46% of the control mice died, whereas about 95% of the Mac-p38a KO mice were still alive (Fig. 1F ). Long-term survival was observed in 27% of the control mice and 68% of the Mac-p38a KO mice (Fig. 1F) . Overall, Mac-p38a KO mice had a significantly higher survival rate than control mice after GalN/TNF-a injection, suggesting that deletion of p38a in macrophages could reduce the mortality from GalN/TNF-a.
Mac-p38a KO mice had less liver injury after GalN/TNF-a treatment
We next examined the extent of liver injury in Macp38a KO and control mice after GalN/TNF-a treatment. As shown in Fig. 1G , both control group and Mac-p38a KO mice showed abnormal liver histology including swelling, necrosis, damaged structure of hepatic cord, nuclear fragmentation, vacuolization, inflammatory cell invasion, and intrahepatic cholestasis after GalN/TNF-a treatment. However, Mac-p38a KO mice exhibited less liver injury compared with control mice after GalN/TNF-a treatment (Fig. 1G) , as evident from less cell damage and inflammatory invasion, and milder hepatic cord disruption and cholestasis, indicating that loss of p38a in macrophages could relieve the GalN/TNF-a-induced liver injury. Histological grading of hematoxylin and eosin (H&E)-stained sections confirmed less liver injury in GalN/TNF-a-treated Macp38a KO mice compared with control mice (Fig. 1H) . Although serum aspartate transaminase (AST) and alanine aminotransferase (ALT) levels remained unchanged 3 h after injury compared with control group (Fig. 1I,J) , Mac-p38a KO mice had significantly decreased serum AST and serum ALT levels compared with littermate controls 6 h after GalN/TNF-a and control (Con) mice (*P < 0.05, **P < 0.01 as compared with control mice; n = 9-10). (I, J) Serum AST (I) and ALT (J) levels in Macp38a KO (KO) and littermate control (Con) mice at 1, 3, and 6 h after treatment (*P < 0.05, ***P < 0.001 as compared with control mice; n = 4-6). Con, blue bars; Macp38a KO, red bars.
administration (Fig. 1I,J) . Together, these findings indicated that ablation of p38a in macrophages could protect liver from GalN/TNF-a-induced injury.
Loss of macrophage p38a decreased the hepatic apoptosis after injury
To determine whether the decreased mortality and the relieved injury in liver were due to a decrease in hepatocyte apoptosis, DNA fragmentation of hepatocyte was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. We found that the number of TUNEL-positive hepatocytes was significantly decreased in the liver sections from Macp38a KO mice compared with control mice 5 h after GalN/TNF-a treatment ( Fig. 2A-C ). In agreement with this finding, caspase 3 activity was significantly decreased in the liver of Mac-p38a KO mice compared with control mice 6 h after GalN/TNF-a treatment (Fig. 2D) . Consistent with this, the levels of cleaved caspase 3 also significantly decreased in the liver of Mac-p38a KO mice compared with control mice after GalN/TNF-a treatment (Fig. 2E ). In addition, Mcl-1, which is a member of the Bcl-2 family and acts as an anti-apoptotic protein, was increased noticeably in the liver of Mac-p38a KO mice compared with control mice 6 h after GalN/TNF-a injection (Fig. 2F ). These data suggested that loss of macrophage p38a could lessen the GalN/TNF-a-induced liver injury through decreasing the hepatic apoptosis.
Hepatocyte regeneration was accelerated in Macp38a KO mice after injury Acute GalN effects on hepatocytes have been classified into two stages, injury and regeneration [5] . Liver regeneration is also known to be important for survival after GalN overdose. In our study, approximately half of the control mice died within 10 h after GalN/TNF-a treatment. Therefore, we investigated the liver regeneration 6 h after GalN/TNF-a administration. The liver of Mac-p38a KO mice showed significantly increased mRNA expression of cell cycle-related genes, such as cyclin D1, cyclin E (CCNE) 1, cyclin E2 and cyclindependent kinase (CDK) 1 ( Fig. 3A-D) . In contrast, p21, known to inhibit proliferation, was downregulated significantly (Fig. 3E ). The protein levels of cyclin D1 were significantly elevated in the liver of Mac-p38a KO mice 6 h after GalN/TNF-a injection (Fig. 3F ). These data indicated that the regeneration process was accelerated in the liver of Mac-p38a KO mice after GalN/ TNF-a treatment.
SB203580-treated macrophages could inhibit apoptosis and promote proliferation of hepatocytes
The effect of macrophage p38a deficiency on GalN/ TNF-a-induced apoptosis was further confirmed in vitro. The protein levels of activated caspase 3 in HepG2 cells were elevated after the addition of the cell culture supernatant of GalN/TNF-a-treated RAW264.7 cells to the culture medium, while the cell culture supernatant of RAW264.7 cells treated with both GalN/TNF-a and SB203580 did not have this effect (Fig. 4A) . Accordingly, we found that the cell culture supernatant from SB203580-treated RAW264.7 cells could increase the protein expression of Mcl-1 in HepG2 cells (Fig. 4A ). In agreement with our in vivo results, we found that the cell culture supernatant of SB203580-treated RAW264.7 cells was able to increase the mRNA expression of cyclin D1 and CDK1 and the protein levels of c-myc and cyclin D1 in HepG2 cells compared with the supernatant of RAW264.7 cells treated with only GalN/TNF-a ( Fig. 4B-D) . These in vitro data further suggested that loss of macrophage p38a could ameliorate the GalN/TNF-a-induced liver injury through decreasing apoptosis and promoting proliferation of hepatocytes.
Deletion of macrophage p38a could suppress granulocytes recruitment and monocytes infiltration after injury
To evaluate the inflammatory response, immunofluorescence staining of CD68 and Ly6G was performed to image the macrophages and granulocytes, respectively, after GalN/TNF-a injection for 5 h. CD68 staining revealed that the number of hepatic macrophages was lower in Mac-p38a KO mice compared with control mice after GalN/TNF-a treatment (Fig. 5A,B) . The number of Ly6G-positive granulocytes was markedly increased in the liver of both Mac-p38a KO and control mice after GalN/TNF-a administration. However, Macp38a KO mice had fewer Ly6G-positive granulocytes in the liver compared with control mice 5 h after treatment (Fig. 5C,D) . The granulocyte recruitment and monocytes infiltration in the liver of mice after GalN/TNF-a treatment were further analyzed by flow cytometry (Fig. 5E-I ). We did not observe any changes in the number of CD45 + F4/80 + CD11b int resident macrophages (KCs) in the liver of Mac-p38a KO mice compared with control mice either with or without GalN/ TNF-a treatment (Fig. 5F ). Consistently, we found that the numbers of both CD45 + F4/80 + CD11b + monocyte-derived macrophages (MDMs) and CD45 + Fig. 3 . Accelerated hepatocyte regeneration in Mac-p38a KO mice. (A-D) Relative hepatic mRNA levels for cell cycle-related genes cyclin D1 (A), cyclin E1 (B), cyclin E2 (C) and cyclin-dependent kinase (CDK) 1 (D) determined by qRT-PCR in control (Con) and Mac-p38a KO (KO) mice with or without GalN/TNF-a injection (*P < 0.05, **P < 0.01, ***P < 0.001 as compared with control mice; n = 4-6). (E) QRT-PCR analysis of p21 in liver of Mac-p38a KO (KO) mice and control (Con) mice treated with or without GalN/TNF-a (***P < 0.001 as compared with control mice; n = 4-6). (F) Immunoblots of total hepatic cyclin D1 from 6 h GalN/TNF-a-treated control (Con) and Mac-p38a knockout (KO) mice. The western blot results are representative of four experiments. Con, blue bars; Mac-p38a KO, red bars.
+ granulocytes were decreased in the liver of Mac-p38a KO mice compared with control mice after GalN/TNF-a treatment (Fig. 5G,H) . In addition, a reduced number of CD45
À monocytes was observed in the liver of Mac-p38a KO mice compared with control mice after injury (Fig. 5I ). These data suggested that the granulocyte recruitment and monocyte infiltration were decreased in the liver of Mac-p38a KO mice after GalN/TNF-a treatment.
p38a deficiency altered the cytokine production in macrophages after injury
To further investigate the effect of p38a loss on the inflammatory response after injury, the serum levels of cytokines and chemokines were determined in Macp38a KO mice ( Fig. 6A-F) . We found that the serum levels of TNF-a, IL-6, IFN-c, monocyte chemoattractant protein-1 (MCP-1; CCL2), and IL-12p70 were reduced in Mac-p38a KO mice compared with control mice 1 h after GalN/TNF-a treatment (Fig. 6A-D,F) . Decreased serum levels of IFN-c and chemokine (C-C motif) ligand 5 (CCL5) were observed in Mac-p38a KO mice compared with control mice 6 h after GalN/ TNF-a treatment (Fig. 6C,E) . The protein levels of cytokines and chemokines were also examined in the liver homogenate from GalN/TNF-a-treated Macp38a KO mice ( Fig. 7A-E) . Consistent with the results obtained from serum samples, we found that the protein levels of TNF-a, IL-6, IFN-c, and MCP-1 (CCL2) were decreased in the liver homogenate from Macp38a KO mice compared with control mice 1 h after GalN/TNF-a treatment ( Fig. 7A-D) . Decreased protein levels of TNF-a, IFN-c, and CCL5 were observed in the liver homogenate from Mac-p38a KO mice compared with control mice 6 h after GalN/TNF-a treatment (Fig. 7A ,C,E). We also determined the mRNA levels of cytokines and chemokines in the liver of GalN/TNF-a-treated Mac-p38a KO mice. To our surprise, the mRNA levels of both TNF-a and IL-6 were increased in the liver of Mac-p38a KO mice compared with control mice 1 h after GalN/TNF-a administration (Fig. 7F,G) . This result suggested that the decreased protein levels of TNF-a and IL-6 observed in the liver of Mac-p38a KO mice 1 h after GalN/ TNF-a treatment were not due to the alteration of their mRNA expression. In contrast, reduced mRNA expression of IFN-c was observed in the liver of Macp38a KO mice either 1 or 6 h after GalN/TNF-a treatment (Fig. 7H) , which was consistent with the results obtained from liver homogenate (Fig. 7C ) and serum samples (Fig. 6C ). In addition, we found that the mRNA expression of IL-1a, IL-1b, and IL-18 was decreased in the liver of Mac-p38a KO mice compared with control mice at different times after GalN/TNF-a treatment as indicated (Fig. 7I,K) . Moreover, the mRNA levels of MCP-1 (CCL2) and its receptor CCR2 were reduced in the liver of Mac-p38a KO mice compared with control mice 1 and 6 h after GalN/ TNF-a treatment, respectively (Fig. 7L,M) . Furthermore, a reduced mRNA level of CCL5 was observed in Mac-p38a KO mice compared with control mice 6 h after GalN/TNF-a administration (Fig. 7N) . We did not detect any changes of the mRNA expression of CCR5, the receptor for CCL5, in Mac-p38a KO mice compared with control mice after GalN/TNF-a treatment (Fig. 7O) . Collectively, these data suggested that the cytokine production was altered in Mac-p38a KO mice, which might contribute to the reduced inflammatory response after GalN/TNF-a treatment.
Macrophage polarization was affected in Macp38a KO mice after injury
It is known that macrophage polarization is important and prolonged activation of M1-type macrophages is harmful for tissue repair. To test whether the polarization of macrophages was affected in Mac-p38a KO mice, we examined the M1 and M2 markers after GalN/ TNF-a treatment. As shown in Fig. 8 , the mRNA expression of M1 markers (NOS2, CD86, and COX2) was downregulated (Fig. 8A-C) , while the mRNA expression of M2 markers (Fizz1, MRC1, and ARG1) was upregulated (Fig. 8D-F) in the liver tissues of Macp38a KO mice after injury. The effect of p38a loss on macrophage polarization was further analyzed by flow cytometry (Fig. 8G-M) . We found that both the proportion and the number of CD206 + KCs were increased in GalN/TNF-a-treated Mac-p38a KO mice compared with control mice (Fig. 8H,I ). In addition, we found that both the proportion and the number of CD206 + MDMs were increased (Fig. 8J,K) , while both the proportion and the number of MHCII + MDMs were decreased in GalN/TNF-a-treated Mac-p38a KO 
(F-I) Quantification of KC (F), MDM (G), granulocytes (H)
, and monocytes (I) in liver NPCs untreated or treated with GalN/TNF-a for 1 h in Mac-p38a knockout (KO) and littermate control (Con) mice (*P < 0.05, ***P < 0.001 as compared with control mice; n = 4). Con, blue bars; Mac-p38a KO, red bars.
mice compared with control mice (Fig. 8L,M) . These data indicated that p38a loss could promote the polarization of macrophages from the M1 phenotype to the M2 phenotype. To further investigate the role of p38a in the modulation of macrophage polarization, LPS/ IFN-c and IL-4 were employed to induce the M1 and M2 macrophage phenotype, respectively [20] . We first analyzed the phosphorylation p38a and its downstream signaling during macrophage polarization in vitro. The phosphorylation of p38a, CREB, and ATF2 was significantly increased during M1 macrophage activation (Fig. 9A) . In contrast, no obvious activation of p38a, CREB, and ATF2 was observed during M2 macrophage polarization (Fig. 9A) . Interestingly, deletion of p38a in macrophages suppressed the mRNA expression of M1 markers (TNF-a, IL-6, CD86, and NOS2) in response to LPS/IFN-c stimulation (Fig. 9B) . On the other hand, loss of p38a in macrophages markedly augmented the mRNA expression of M2 markers (Ym-1, ARG1, and MRC1) in response to IL-4 stimulation (Fig. 9C) . Accordingly, western blot analysis showed that the protein level of NOS2 (M1 marker) was markedly decreased by SB203580 treatment in RAW264.7 cells upon LPS/ IFN-c stimulation (Fig. 9D) , and the protein level of Ym-1 (M2 marker) was elevated by SB203580 treatment in RAW264.7 cells upon IL-4 stimulation (Fig. 9E) . Consistent with these findings, flow cytometry analysis revealed that inhibition of p38a by SB203580 could either suppress LPS/IFN-c-induced M1 macrophage polarization (Fig. 9F,G) or promote IL-4-induced M2 macrophage polarization (Fig. 9F,H ) in RAW264.7 cells. Together, these data indicated that deletion of p38a could affect macrophage polarization toward an M2-like phenotype.
p38a loss led to downregulation of CREB phosphorylation and C/EBPb expression
To further elucidate how p38a deficiency affects the cytokine production of macrophages, we next examined the activation of inflammatory pathways in macrophages. Since MAPK pathways are important in cytokine production, phosphorylation of p38, c-Jun N-terminal kinase (JNK), and extracellular signalregulated kinase (ERK) was examined by western blot analysis. As expected, LPS/IFN-c stimulation resulted in phosphorylation of p38 in control BMDMs (Fig. 10A) . In contrast, the phosphorylation of p38 by LPS/IFN-c stimulation was almost abolished in BMDMs from Mac-p38a KO mice (Fig. 10A) . These results suggested that p38a is the dominant p38 isoform in macrophages and loss of p38a would greatly impair the p38 signaling upon induction of M1 macrophages (Fig. 10A) . LPS/IFN-c stimulation also led to phosphorylation of JNK and ERK in BMDMs (Fig. 10A) . However, the phosphorylation of JNK and ERK by LPS/IFN-c stimulation was not affected by deletion of p38a (Fig. 10A) . It is widely believed that transcription factors NF-jB, C/EBPb, and CREB play important roles in proinflammatory cytokine production. Thus, we examined whether these transcription factors were affected in BMDMs after the deletion of p38a. We found that the phosphorylation of p65 was not affected by p38a deletion (Fig. 10A) , while the phosphorylation of CREB was significantly reduced (Fig. 10B ) and the expression of C/EBPb was almost abolished by p38a knockout (Fig. 10C) . It has been reported that there were at least two CREB binding sites in the promoter of C/EBPb [28] , and LPS stimulation could induce recruitment of CREB to the , and IL-12p70 (F) levels in control (Con) and Mac-p38a KO (KO) mice that were untreated (0 h) or treated for the indicated number of hours with GalN/TNF-a (*P < 0.05, **P < 0.01, ***P < 0.001 as compared with control mice; n = 5-8). Con, blue bars; Mac-p38a KO, red bars.
C/EBPb promoter in the J774 macrophage cell line [29] . Here, we found that treatment with CREB inhibitor KG-501 attenuated the C/EBPb mRNA expression induced by LPS/IFN-c (Fig. 10D) . In addition, our in vitro data showed that treatment of RAW264.7 cells with CREB inhibitor KG-501 could attenuate the effect of GalN/TNF-a on the protein levels of activated caspase 3 in HepG2 cells (Fig. 10E) . Based on these results, we concluded that the decreased cytokine production might be due to the impaired p38a-CREB-C/EBPb signaling pathway, which ameliorated the GalN/TNF-a-induced liver injury.
Discussion
Management of acute liver failure due to drug-induced hepatotoxicity is one of the most challenging problems in clinical medicine. Despite the molecular basis of drug toxicity and liver injury having been extensively investigated, the scientific understanding of the pathogenesis and progression of acute liver failure is still evolving. GalN, a specific hepatotoxic agent, has been widely used to induce model ALI to elucidate clinical liver dysfunction, explore the mechanisms involved in liver regeneration, and evaluate the efficiency of and Mac-p38a KO (KO) mice that were untreated (0 h) or treated for the indicated number of hours with GalN/TNF-a (*P < 0.05, **P < 0.01, ***P < 0.001 as compared with control mice; n = 5-8). (F-O) Relative hepatic mRNA levels for TNF-a (F),
, and CCR5 (O) determined by qRT-PCR in control (Con) and Mac-p38a KO (KO) mice that were untreated (0 h) or treated for the indicated number of hours with GalN/TNF-a (*P < 0.05, **P < 0.01, ***P < 0.001 as compared with control mice; n = 5-8). Con, blue bars; Mac-p38a KO, red bars.
hepatoprotective agents [30] . TNF-a or LPS is always used together with GalN to enhance the phenotype [31] [32] [33] . Here, we observed decreased liver injury in GalN/TNF-a-treated Mac-p38a KO mice (Fig. 1G,H) . When macrophage p38a was deleted, mice were protected against GalN/TNF-a-induced hepatotoxicity as evidenced by lower serum ALT/AST levels (Fig. 1I,J) and improved liver morphology and histology (Fig. 1G,H) . These results indicated that p38a deficiency in macrophages has hepatoprotective effects.
Cell death can induce compensatory proliferation of surrounding normal cells to promote the wound-healing response in mammals and other species [34] [35] [36] . It has been proposed that the acute GalN effect on hepatocytes could be classified into two stages of injury and regeneration [5] . In this study, we found that the effect was not only due to reduced apoptosis but also due to accelerated hepatocyte regeneration in Mac-p38a KO mice. Interestingly, in spite of decreased hepatocyte apoptosis in Mac-p38a KO mice (Fig. 2) , compensatory hepatocyte proliferation was significantly increased during the regeneration phase (Fig. 3) . Because most Mac-p38a KO mice died before the peak of liver regeneration, the impaired hepatocyte proliferation might have a minor effect on their higher mortality. p38a has been extensively studied in macrophages, but its role is still controversial [27] . We believe that these discrepancies are probably due to different experimental conditions, cell lines, types of macrophages, and/or different stimuli used. For example, using thioglycollate-elicited murine PMs and an in vivo model of chitin-induced M2 polarization, it was found that p38 might be involved in the signaling of IL-4 leading to M2-macrophage polarization [27] . Given that the role of p38a in macrophage polarization seems to depend on the experimental conditions and the models used, we believe that the role of p38a in macrophage polarization might be cell type-dependent, cell contextdependent, microenvironment-dependent, and/or stress-dependent.
It has been shown that IL-6 plays an important role in liver regeneration. IL-6 is released by nonparenchymal (***P < 0.001 as compared with control mice; n = 3.) Con, blue bars; Mac-p38a KO, red bars.
cells within minutes after partial hepatectomy [37] [38] [39] . IL-6 is a critical factor in the mitogenic response during liver regeneration and is important for protection from liver injury [40] . In our study, we observed reduced serum and protein levels of IL-6 in Mac-p38a KO mice compared with control mice 1 h after GalN/TNF-a treatment ( Figs 6B and 7B) . The discrepancies between the lower IL-6 levels and the lesser liver injury in Mac-p38a KO mice suggested that the decreased serum and protein levels of IL-6 might be the result, not the cause, of less liver injury in Mac-p38a KO mice. Interestingly, we did not see any changes in IL-6 protein levels either in the liver or in the serum of Mac-p38a KO mice 6 h after GalN/TNF-a treatment (Figs 6B and 7B), which might be due to the increased mRNA levels of IL-6 we observed in the liver of Mac-p38a KO mice 1 h after GalN/TNF-a treatment (Fig. 7G ).
It has been reported that TNF-a could induce CCL5 via p38 activation thereby contributing to liver injury [41] . Similarly, it has been suggested that TNFa could regulate CCL2 via p38 activation [42] . Moreover, it has been shown that CCR5-deficient mice show a shift in macrophage polarization toward M2 macrophages [43] . Consistent with these reports, we observed decreased serum levels, protein levels, and mRNA levels of CCL2 in Mac-p38a KO mice compared with control mice 1 h after GalN/TNF-a administration ( Figs 6D and 7D,L) . Moreover, we found that serum levels, protein levels, and mRNA levels of CCL5 were all decreased in Mac-p38a KO mice compared with control mice 6 h after GalN/TNF-a treatment ( Figs 6E and 7E,M) .
To further investigate the effect of p38a on cytokine production, we examined the p38-MAPK signaling pathways. In this study, we found that the phosphorylation of p38a and its downstream CREB was increased by GalN/TNF-a compared with the control group. Deletion of p38a significantly decreased the phosphorylation level of CREB. In addition, we found that the expression of C/EBPb was also blocked due to the deficiency of p38a. Given that C/EBPb can promote the transcription of IL-6 through binding to its promoter, as well as to regulatory regions of several acute-phase and cytokine genes, our data indicated that deletion of p38a might decrease the inflammatory response through regulating the p38a-CREB-C/EBPb pathway.
In conclusion, we have demonstrated that macrophage deficiency of p38a might play a critical role in protection against GalN/TNF-a-induced ALI in mice by inhibiting hepatocyte apoptosis in the initial injury phase and promoting liver regeneration in the later phase. Our observations also indicate that macrophage p38a would be a potential therapeutic target for GalN/TNF-a-induced liver injury. In the survival experiment, we removed challenged mice when they lost their righting reflex and reaction to pain stimuli [45] . All animals received humane care, and animal experiments were performed in accordance with procedures and protocols approved by the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China). 
Experimental procedures
Animal model
Preparation of bone marrow-derived macrophages
Murine BMDMs were differentiated from bone marrow of 8-to 10-week-old male mice by culturing in 19 RPMI 1640, 10% fetal bovine serum, 1% penicillin/streptomycin, and 20% L-929 conditioned medium for 7 days.
Serum assays
Blood samples were collected at 0, 1, 3 and 6 h after 
Histological analysis
Mouse livers were fixed for 24 h in 4% neutral paraformaldehyde, then washed, dehydrated, and embedded in paraffin. Liver sections (4 lm) were stained with H&E. To evaluate the degree of necrosis after ALI, we used an injury grading score (Grades I-IV) based on severity of necrotic lesions in the liver parenchyma [46, 47] .
TUNEL assay of liver sections
Liver sections (4 lm) were deparaffinized and rehydrated. Cells with nuclear DNA fragmentation were detected using the In Situ Cell Death Detection Kit, Fluorescein (Roche Applied Science, Indianapolis, IN, USA) according to the manufacturer's protocol. For each liver section per mouse, the numbers of TUNEL-positive cells were counted at 9400 magnification under light microscopy, with 10 highpower fields randomly selected, TUNEL-positive cells were counted, and the percentage of positive cells (Apoptotic cells %) was calculated.
Isolation of liver nonparenchymal cells and Kupffer cells
Liver nonparenchymal cells (NPCs) were isolated as previously reported [48] . Briefly, minced liver was digested by 1 mgÁmL À1 collagenase I, 1.5 mgÁmL À1 collagenase IV (Worthington Biochemical Corp., Lakewood, NJ, USA), and 40 lgÁmL À1 DNase I (Roche Life Science) in Hanks'
balanced salt solution for 1 h at 37°C. After enzymatic digestion, liver was mashed on a 70-lm cell strainer (BD Biosciences, San Jose, CA, USA). Then, hepatocytes were removed by centrifugation at 50 g for 2 min three times. Then, liver NPCs were obtained by centrifugation of the supernatant at 500 g for 10 min followed by removal of red blood cells with RBC lysis buffer. Liver macrophages were isolated as previously reported [49] with a little modification. Briefly, liver NPCs isolated using the sedimentation method were further purified with density gradient Percoll centrifugation.
Flow cytometry
Flow cytometry and cell population sorting were performed on a FACSAria flow cytometer (BD Biosciences), using a range of antibodies. Flow cytometry data were analyzed using FLOWJO (v.9 or v.10; Tree Star, Ashland, OR, USA). Phycoerythrin (PE)-cyanine7-conjugated anti-CD45 (eBioscience, San Diego, CA, USA), BV421-conjugated anti-F4/ 80 (BioLegend, San Diego, CA, USA), FITC-conjugated anti-CD11b (eBioscience, San Diego, CA, USA), PerCPCy5.5-conjugated anti-Ly-6G (BD Biosciences), allophycocyanin (APC)-conjugated anti-Ly-6G (BD Biosciences), PEconjugated anti-MHCII (BD Biosciences), and APC-conjugated-anti-CD206 (BioLegend) antibodies were used.
Immunofluorescence microscopy
Livers were embedded in optimal cutting temperature compound and stored in À80°C. Sections (5-10 lm) were obtained in a cryostat, collected on poly-L-lysine-coated slides, fixed in cold acetone for 10-15 min, dried in air and rehydrated in PBS. Then, slides were blocked for 1 h in 3% bovine serum albumin (Sigma-Aldrich), incubated overnight with anti-CD68 (BioLegend) or anti-Ly6G (BioLegend) antibody at 4°C, then washed with PBS and incubated for 2 h with Cy3-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). The tissues were then washed and stained with 4 0 ,6-diamidino-2-phenylindole. After washing with PBS, tissues were mounted in anti-fading medium containing 4 0 ,6-diamidino-2-phenylindole (Thermo Fisher Scientific, Waltham, MA, USA) and visualized by fluorescence microscopy (Carl Zeiss, Oberkochen, Germany).
Protein isolation and immunoblotting
Western blot analysis was performed as described before with minor modification [50] . Briefly, cultured RAW264.7 or HepG2 cells, or isolated primary cells, or mouse tissues were homogenized in RIPA lysis buffer (Beyotime, Shanghai, China) supplemented with Protease Inhibitor Cocktail and Phosphatase Inhibitor Cocktail (Roche). Protein concentration was determined using a BCA protein assay kit (Thermo Fisher Scientific). Protein lysates were resolved on 10% SDS/PAGE under reducing conditions, electrotransferred to polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA), and then exposed to indicated antibodies, which were then detected by chemiluminescence methods. Anti-caspase 3, anti-Mcl-1, anti-cyclin D1, anti-c-myc, anti-p38a, anti-phospho-p38a, anti-NOS2, anti-CREB, anti-phospho-CREB anti-phospho-p65, and anti-heat shock protein 90 (HSP90) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-a-tubulin antibody was from Sigma-Aldrich, anti-Ym1 antibody was from R&D, and anti-C/EBPb was from Santa Cruz Biotechnology (Dallas, TX, USA).
Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR)
Tissue and cell RNA were extracted using Trizol reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. Reverse transcription with 1 lg of RNA was carried out using PrimeScript RT reagent Kit (Takara, Dalian, China). qRT-PCR was performed on an ABI 7900 Real-Time PCR System (Thermo Fisher Scientific). The primer sequences used are provided in Table S1 . Data analysis was normalized to levels of 18S (tissues and HepG2) or L32 (macrophage and RAW264.7).
Statistical analysis
Numerical results are reported as means AE SEM and derived from at least three independent experiments unless otherwise indicated. Student's unpaired t test was used to assess significance between two groups. Calculations for statistical differences between various groups were carried out by two-way ANOVA, followed by the Bonferroni correction for multiple tests. Survival rates between control and Mac-p38a KO mice were analyzed by Kaplan-Meier survival and log-rank tests. Statistical significance was defined as *P < 0.05. The software used was Microsoft Excel and PRISM 5.0 (GraphPad Software, San Diego, CA, USA).
